Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.670
+0.180 (4.01%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Employees
As of June 30, 2025, Neuphoria Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,178,892
Market Cap
25.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2024 | 8 | - | - | 8 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| Palatin Technologies | 29 |
| NeuroSense Therapeutics | 17 |
| Barinthus Biotherapeutics | 14 |
| Skye Bioscience | 12 |
| Allarity Therapeutics | 8 |
| Marker Therapeutics | 5 |
NEUP News
- 24 days ago - Neuphoria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 24 days ago - Neuphoria Therapeutics Quarterly report: Q3 2026 - Filings
- 3 months ago - Neuphoria Therapeutics Quarterly report: Q2 2026 - Filings
- 6 months ago - Neuphoria announces ISS recommends shareholders vote ‘FOR’ director nominees - TheFly
- 6 months ago - Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees - GlobeNewsWire
- 6 months ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 6 months ago - Neuphoria Therapeutics price target lowered to $7 from $21 at H.C. Wainwright - TheFly
- 6 months ago - Neuphoria Therapeutics responds to Lynx1’s revised indication of interest - TheFly